Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.10.2022 | Case report

SARS-COV-2 vaccine inactivated Sinovac Biotech

Erythrodermic psoriasis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhao Z, et al. Vaccine-induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review. Dermatologic Therapy 35: No. 9, Sep 2022. Available from: URL: http://doi.org/10.1111/dth.15684 Zhao Z, et al. Vaccine-induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review. Dermatologic Therapy 35: No. 9, Sep 2022. Available from: URL: http://​doi.​org/​10.​1111/​dth.​15684
Metadaten
Titel
SARS-COV-2 vaccine inactivated Sinovac Biotech
Erythrodermic psoriasis: case report
Publikationsdatum
01.10.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-25592-1

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

AZD-1222